We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$80.1B
AUM Growth
+$9.71B
Cap. Flow
+$17.3B
Cap. Flow %
21.56%
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$13B
2
NVDA icon
NVIDIA
NVDA
+$468M
3
ASML icon
ASML
ASML
+$424M
4
AMAT icon
Applied Materials
AMAT
+$310M
5
QCOM icon
Qualcomm
QCOM
+$307M

Top Sells

Rank Stock Value
1
KGC icon
Kinross Gold
KGC
+$444M
2
TYL icon
Tyler Technologies
TYL
+$256M
3
CHRW icon
C.H. Robinson
CHRW
+$251M
4
PM icon
Philip Morris
PM
+$245M
5
RTX icon
RTX Corp
RTX
+$234M

Sector Composition

Rank Sector Weight
1 Technology 40.76%
2 Materials 26.89%
3 Healthcare 7.04%
4 Industrials 6.5%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AU icon
26
AngloGold Ashanti
AU
$40.7B
$691M 0.86%
22,920,684
+80,563
+0.4% +$2.31M
CDNS icon
27
Cadence Design Systems
CDNS
$93.4B
$689M 0.86%
2,767,965
+572,251
+26% +$158M
MRVL icon
28
Marvell Technology
MRVL
$170B
$611M 0.76%
7,471,823
+1,570,050
+27% +$108M
MCHP icon
29
Microchip Technology
MCHP
$42.3B
$599M 0.75%
7,961,200
+1,597,263
+25% +$132M
BTG icon
30
B2Gold
BTG
$5.16B
$566M 0.71%
166,079,133
+47,967,010
+41% +$139M
RGLD icon
31
Royal Gold
RGLD
$17.1B
$554M 0.69%
3,637,739
+39,394
+1% +$5.39M
GILD icon
32
Gilead Sciences
GILD
$162B
$553M 0.69%
6,342,831
+22,847
+0.4% +$1.74M
CTVA icon
33
Corteva
CTVA
$58.6B
$541M 0.68%
8,902,675
+213,872
+2% +$11.7M
BMY icon
34
Bristol-Myers Squibb
BMY
$128B
$527M 0.66%
9,933,591
+781,385
+9% +$36.7M
TRU icon
35
TransUnion
TRU
$14.9B
$520M 0.65%
4,783,301
-151,985
-3% -$13.7M
MKTX icon
36
MarketAxess Holdings
MKTX
$4.19B
$510M 0.64%
1,764,239
-63,816
-3% -$15M
ADSK icon
37
Autodesk
ADSK
$47.7B
$492M 0.61%
1,717,367
+74,394
+5% +$18.7M
ALLE icon
38
Allegion
ALLE
$13.4B
$480M 0.6%
3,178,952
+39,905
+1% +$5.28M
USB icon
39
US Bancorp
USB
$98.9B
$478M 0.6%
9,852,013
+373,559
+4% +$16.4M
PFE icon
40
Pfizer
PFE
$141B
$478M 0.6%
16,560,256
+456,168
+3% +$13.3M
CRM icon
41
Salesforce
CRM
$142B
$462M 0.58%
1,624,520
+794,506
+96% +$204M
HII icon
42
Huntington Ingalls Industries
HII
$11.4B
$455M 0.57%
1,778,210
+863,800
+94% +$229M
KVUE icon
43
Kenvue
KVUE
$37.4B
$445M 0.56%
19,550,250
-960,177
-5% -$19.9M
BIO icon
44
Bio-Rad Laboratories Class A
BIO
$8.47B
$437M 0.55%
1,303,752
+644,530
+98% +$205M
VEEV icon
45
Veeva Systems
VEEV
$31.6B
$434M 0.54%
1,995,006
+71,525
+4% +$14.1M
BF.B icon
46
Brown-Forman Class B
BF.B
$12.6B
$430M 0.54%
8,822,514
+4,445,128
+102% +$200M
ADBE icon
47
Adobe
ADBE
$94.5B
$429M 0.54%
884,016
+8,176
+0.9% +$4.48M
EMR icon
48
Emerson Electric
EMR
$83.6B
$423M 0.53%
3,896,889
+2,016,075
+107% +$217M
MSFT icon
49
Microsoft
MSFT
$2.89T
$420M 0.52%
989,062
+66,922
+7% +$28.6M
IFF icon
50
International Flavors & Fragrances
IFF
$19.5B
$416M 0.52%
4,000,621
-448,542
-10% -$44.7M

Similar funds

VanEck Associates's Q3 2024 Portfolio in Review

As of Q3 2024, VanEck Associates held 1,430 positions worth $80.1B, up 14% from $70.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VanEck Associates deployed $17.3B of net new capital in Q3 2024, opening 62 new positions and adding to 858 existing holdings. Its largest new stake was GE HealthCare: 2,335,235 shares worth $209M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Healthcare.

On the sell side, the largest reduction was Kinross Gold, an estimated $444M trimmed.

  • VanEck Associates's largest Q3 2024 buy was GE HealthCare: 2,335,235 shares worth $209M.
  • VanEck Associates added most to Lam Research in Q3 2024, an estimated $13B increase.
  • VanEck Associates's biggest Q3 2024 reduction was Kinross Gold, cutting an estimated $444M.
  • VanEck Associates fully exited RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock in Q3 2024, selling an estimated $22.4M.
  • VanEck Associates's ten largest holdings make up 29% of its $80.1B portfolio in Q3 2024.
  • VanEck Associates opened 62 new positions and closed 53 in Q3 2024.
  • VanEck Associates's portfolio value rose 14% quarter-over-quarter to $80.1B.

Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.